Detalhe da pesquisa
1.
Targeted RNA-seq successfully identifies normal and pathogenic splicing events in breast/ovarian cancer susceptibility and Lynch syndrome genes.
Int J Cancer
; 145(2): 401-414, 2019 07 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-30623411
2.
Correlated evolutionary rates across genomic compartments in Annonaceae.
Mol Phylogenet Evol
; 114: 63-72, 2017 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-28578201
3.
Naturally occurring BRCA2 alternative mRNA splicing events in clinically relevant samples.
J Med Genet
; 53(8): 548-58, 2016 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-27060066
4.
Next-Generation Sequencing in Oncology: Genetic Diagnosis, Risk Prediction and Cancer Classification.
Int J Mol Sci
; 18(2)2017 Jan 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-28146134
5.
Comprehensive annotation of splice junctions supports pervasive alternative splicing at the BRCA1 locus: a report from the ENIGMA consortium.
Hum Mol Genet
; 23(14): 3666-80, 2014 Jul 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-24569164
6.
Emerging importance of chemokine receptor CXCR3 and its ligands in cardiovascular diseases.
Clin Sci (Lond)
; 130(7): 463-78, 2016 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-26888559
7.
A randomised controlled phase II trial of pre-operative celecoxib treatment reveals anti-tumour transcriptional response in primary breast cancer.
Breast Cancer Res
; 15(2): R29, 2013 Apr 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-23566419
8.
A guide for functional analysis of BRCA1 variants of uncertain significance.
Hum Mutat
; 33(11): 1526-37, 2012 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-22753008
9.
Detection of exon skipping events in BRCA1 RNA using MLPA kit P002.
Mol Biol Rep
; 39(7): 7429-33, 2012 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-22350158
10.
Phylogenomics of the Major Tropical Plant Family Annonaceae Using Targeted Enrichment of Nuclear Genes.
Front Plant Sci
; 9: 1941, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-30687347
11.
Full in-frame exon 3 skipping of BRCA2 confers high risk of breast and/or ovarian cancer.
Oncotarget
; 9(25): 17334-17348, 2018 Apr 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-29707112
12.
BRCA1 c.4987-3C>G is a pathogenic mutation.
Breast Cancer Res Treat
; 131(2): 723-5, 2012 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-22113256
13.
Familial breast/ovarian cancer and BRCA1/2 genetic screening: the role of immunohistochemistry as an additional method in the selection of patients.
J Histochem Cytochem
; 55(11): 1105-13, 2007 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-17625228
14.
Screening for a BRCA2 rearrangement in high-risk breast/ovarian cancer families: evidence for a founder effect and analysis of the associated phenotypes.
J Clin Oncol
; 25(15): 2027-34, 2007 May 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-17513806